TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer - Test2 - elhamkhani - TriplyDB

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer

http://www.wikidata.org/entity/Q28393844

about

Human Specific Regulation of the Telomerase Reverse Transcriptase Gene Gene aberrations for precision medicine against lung adenocarcinoma The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.The importance of detailed epigenomic profiling of different cell types within organs.Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.Telomere Maintenance Mechanisms in Cancer.Subtype variation and actionability of telomere length abnormality in lung cancer

P2860

Q26745549-D61806BF-BB0C-426A-B218-FA2C2747497B Q26749348-A2DFA409-FF55-4837-A474-23BDAA80F61B Q28392404-6DA00CAC-4147-4328-BB33-5D708C1D62CA Q28392499-F38D0B00-9EBA-4B42-9FAC-1B0CB8C71FF0 Q33618591-1C0D1257-630C-4656-84E0-6C16E7956AA1 Q33888923-0C2D83FB-9955-4770-9E35-827CAC98E31C Q36882598-0FAB9799-28D4-4811-9840-BB20CB266003 Q37166233-43DBF7D7-DB1E-4BE3-BD64-5F843D35CC70 Q37293282-C9070153-5AC9-44FE-A060-AE641EF1DEE9 Q37342804-050EF7BB-B1B8-44DE-B4C9-E36F50C26310 Q40511105-0B172395-CFD2-486F-8FA6-A3030521FDAF Q55443450-68FF7F98-7DE1-49B4-B836-7F1342E4D5E5 Q58562388-B0B11310-276A-4417-A82B-60C1EE99C4F1

P2860

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer

http://www.wikidata.org/entity/Q28393844

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@ast

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@en

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@nl

type

label

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@ast

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@en

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@nl

prefLabel

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@ast

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@en

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@nl

P1433

Q28393844-90613FEA-7860-4374-8574-495EC5449627

P1476

Q28393844-AC96A776-C008-4816-97AE-1914162067B6

P2093

Q28393844-1BF64362-5E7E-4489-B39E-AC9DC4054EAA

Q28393844-34C27874-D3D0-4EB2-A6B4-B4E1C0EDB975

Q28393844-35449A8A-306D-4B0E-BC00-C578AB7FCB2E

Q28393844-40F43DF6-743C-4D3F-8C41-EC7F9B6DAF4C

Q28393844-606CB053-B832-49AE-8636-2D8A4B8AB5FD

Q28393844-734B1F17-4443-46BC-8D70-A891A7FA8CF1

Q28393844-7D23E76E-AC1D-463E-8864-2F28870FE1BE

Q28393844-9A67FC65-2F42-403E-BAAF-7FBB2AEB2172

Q28393844-9C0AEE31-9E6F-41B4-95F0-F925F284D7AC

Q28393844-9D78C7EB-B180-454B-AA91-CF44D250AAF6

P2860

Q28393844-067B2EAC-1745-4961-AB63-7AFB2A8C099F

Q28393844-10C64C4D-8274-443C-BD72-0074024D9B56

Q28393844-17603F1B-05AD-4D71-84C3-63563C7896D3

Q28393844-17CEE7AC-6279-4FAF-8BC4-4049D554F45E

Q28393844-182A24ED-2888-4ED8-BE02-BADAC4F4998E

Q28393844-19902CED-09B2-4D38-B2DB-236CBD3ABAD3

Q28393844-20C009C9-F9EE-43C4-B9CC-75AB0A0A0178

Q28393844-2BEF9A1A-1AF7-47F9-BDFB-0535DD3F5BAF

Q28393844-2C14C330-6B4A-4EED-ABFB-AE4659C2B179

Q28393844-2F8E83C4-9EDD-499A-BD51-AB7665E1A37D

P304

Q28393844-3F8FE321-B736-4101-AE82-0BD68056A41E

P31

Q28393844-071ADAEB-BECA-45B0-9F7B-733637746BCC

P3181

Q28393844-F4003798-B573-4514-88B8-6F98A1CDD91C

P356

Q28393844-FC36CB44-0D3B-4051-9463-787054182130

P407

Q28393844-E00170A4-0766-412E-B360-5923E1B1FA1C

P433

Q28393844-C18ECD29-82DA-4668-A527-1917FD7D28E5

P478

Q28393844-D479338D-76E2-4F68-9874-2CA0DFD7DA8F

P50

Q28393844-A8EA2296-B6FF-4B5C-9EA8-723874FD6B6B

P577

Q28393844-22EBC472-16DA-4720-B557-349265131E72

P698

Q28393844-0E9CEF74-17BD-44BA-81C7-716544DE2E76

P932

Q28393844-28E98B62-7863-4F8C-B064-B47E48CA95E1

P3181

P356

1078-0432.CCR-15-0009

P1433

Clinical Cancer Research

P1476

TERT Polymorphism rs2736100-C ...... ive Non-Small Cell Lung Cancer

@en

P2093

Christopher I Amos

http://www.w3.org/2001/XMLSchema#string

Hengying Pu

http://www.w3.org/2001/XMLSchema#string

Hong Zhang

http://www.w3.org/2001/XMLSchema#string

Hongwei Wang

http://www.w3.org/2001/XMLSchema#string

Hui-Yun Wang

http://www.w3.org/2001/XMLSchema#string

Lan Cao

http://www.w3.org/2001/XMLSchema#string

Lanjun Zhang

http://www.w3.org/2001/XMLSchema#string

Murray J Favus

http://www.w3.org/2001/XMLSchema#string

Rongrong Wei

http://www.w3.org/2001/XMLSchema#string

Shun Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study of glioma and meta-analysis

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium

Lung cancer susceptibility locus at 5p15.33

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.

P304

5173-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2009781

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-15-0009

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26149460

http://www.w3.org/2001/XMLSchema#string

P932

4644673

http://www.w3.org/2001/XMLSchema#string